Universität Münster
Clinical trials sponsored by Universität Münster, explained in plain language.
-
New hope for patients who run out of options: dual attack on tough lymphoma
Disease control Not yet recruitingThis study is testing whether combining two newer lymphoma drugs, loncastuximab tesirine and epcoritamab, is safe and effective for people with aggressive B-cell lymphoma that has returned or not responded to prior treatments. It will enroll 120 adults whose disease has progresse…
Phase: PHASE2 • Sponsor: Universität Münster • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
Can a common ICU drug save lives from deadly kidney complication?
Disease control Not yet recruitingThis study aims to find out if giving sodium bicarbonate (a common medication) to critically ill ICU patients who have both acute kidney injury and metabolic acidosis (too much acid in the blood) can improve their chances of survival and recovery 90 days later. It will enroll 660…
Phase: PHASE4 • Sponsor: Universität Münster • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC